Supplementary Figure S3 from Enhanced Antitumor Responses of Tumor Antigen-Specific TCR T Cells Genetically Engineered to Produce IL7 and CCL19

Abstract

Supplementary Figure S3 shows infiltration of immune cells in the tumor tissues after treatment with P1A-T cells with anti-PD-1 mAb.</p